**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 613-29-6 |Benzenamine, N,N-Dibutyl- | 99 | 210-335-6 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause methemoglobinemia, cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood),
convulsions, and death. The toxicological properties of this
substance have not been fully investigated. Methemoglobinemia is
characterized by dizziness, drowsiness, headache, shortness of
breath, cyanosis (bluish discoloration of skin due to deficient
oxygenation of the blood), rapid heart rate and chocolate-brown
colored blood.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated. Methemoglobinemia is
characterized by dizziness, drowsiness, headache, shortness of
breath, cyanosis (bluish discoloration of skin due to deficient
oxygenation of the blood), rapid heart rate and chocolate-brown
blood. Can produce delayed pulmonary edema. Inhalation of aniline
causes anoxia due to the formation of methemoglobin.
Chronic:
May cause methemoglobinemia, which is characterized by
chocolate-brown colored blood, headache, weakness, dizziness, breath
shortness, cyanosis (bluish skin due to deficient oxygenation of
blood), rapid heart rate, unconsciousness and possible death. Effects
may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
Treat symptomatically and supportively. For methemoglobinemia,
administer oxygen alone or with Methylene Blue depending on the
methemoglobin concentration in the blood.
Antidote:
Methylene blue, alone or in combination with oxygen is indicated as
a treatment in nitrite induced methemoglobinemia.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Vapors may be heavier
than air. They can spread along the ground and collect in low or
confined areas. Containers may explode when heated.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Cool containers with
flooding quantities of water until well after fire is out. Use water
spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Avoid contact with
eyes, skin, and clothing. Keep container tightly closed. Avoid
ingestion and inhalation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 613-29-6:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: green - pale-yellow
Odor: aniline-like
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 270 deg C
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: > 110 deg C (> 230.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: .9060g/cm3
Molecular Formula: C14H23N
Molecular Weight: 205.34
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and
gases, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 613-29-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Benzenamine, N,N-Dibutyl- -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 613-29-6: 2
Canada
CAS# 613-29-6 is listed on Canada's NDSL List.
CAS# 613-29-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 613-29-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 6/24/1999 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
N,N-Dibutylaniline, 99% (GC)
| 613-29-6 |
|
1,1,1,3,3,3-Hexafluoroacetone sesquihydrate, 98% (gc)
| 684-16-2 |
|
2-Biphenylyl Glycidyl Ether, 95%
| 7144-65-2 |
|
2,4-Dichlorobenzamide, 98%
| 2447-79-2 |
|
Isobutyl methacrylate, 99% (gc), stabilized with 15-20 ppm MEHQ
| 97-86-9 |
|
Picolinic acid n-oxide, 97%
| 824-40-8 |
|
N,n'-dimethylpiperazine, 98%
| 106-58-1 |
|
1,4-Dichlorobutane
| 110-56-5 |
|
1-Acetyl-4-Piperidinecarboxylic Acid, 99%
| 25503-90-6 |
|
Alpha, Alpha, Alpha-Trifluoro-O-Cresol 99%
| 444-30-4 |
|
Trans 2, cis 6-nonadienal diethylacetal, 80%
| 67674-36-6 |
|
Nitronium tetrafluoroborate,97%
| 13826-86-3 |
|
7-Methylindole, 99%
| 933-67-5 |
|
2,3,4,5,6-Pentafluoroaniline, 97%
| 771-60-8 |
|
9-Hydroxyxanthene, 99%
| 90-46-0 |
|
2'-Methoxyacetophenone, 99%
| 579-74-8 |
|
4-Methylindole, 99%
| 16096-32-5 |
|
Benzo[b]naphtho[2,3-d]furan, tech., 90+% (gc)
| 243-42-5 |
|
2-Methyl-3-nitrophenol, 98 %
| 5460-31-1 |
|
Diethylcarbamyl chloride, 99% (titr.)
| 88-10-8 |
|
2'-Chloroacetophenone, 97%
| 2142-68-9 |
|
Trifluoromethanesulfonic acid, 99%
| 1493-13-6 |
|
Acid Blue 45
| 2861-02-1 |
|
N-Alpha-Carbobenzyloxy-D-Arginine, 99+%
| 6382-93-0 |
|
1,2,7,8-Diepoxyoctane, 97%
| 2426-07-5 |
|
Tetrachlorophthalic anhydride, 98% (contains 0.5% Hexachlorobenzene)
| 117-08-8 |
|
4-Hydroxy-N-Methylpiperidine, 98%
| 106-52-5 |
|
Methyl 2,4-dihydroxybenzoate, 97%
| 2150-47-2 |
|
Calmagite, Indicator Grade
| 3147-14-6 |
|
Magnesium bromide hexahydrate, p.a.
| 13446-53-2 |
|
1,5-Naphthalenedisulfonic Acid Disodium Salt, Monohydrate, 95%
| 1655-29-4 |
|
(S)-(+)-2-Amino-2-Methylbutanedioic Acid, 99%
| 0-00-1 |
|
1-Hexanethiol, 99% (GC)
| 111-31-9 |
|
3-Fluorocinnamic Acid
| 458-46-8 |
|
1-Methyl-1-cyclohexanecarboxylic acid, 99%
| 1123-25-7 |
|
1,2-Ethanedisulfonic Acid Disodium Salt
| 5325-43-9 |
|
2-Aminopyrimidine (Pract)
| 109-12-6 |
|
Copper(II) trifluoromethanesulfonate
| 34946-82-2 |
|
4-Nitrobenzenediazonium tetrafluoroborate (pract), 95% (uv-vis)
| 456-27-9 |
|
D-(-)-Gulose, 93-95%, mixture of anomers
| 4205-23-6 |
|
3-Acetoxyacetophenone, 99%
| 2454-35-5 |
|
1-Hydroxy-2,2,5,5-tetramethyl-3-imidazoline 3-oxide, 99%
| 33455-68-4 |
|
(S)-(+)-Glycidyl nosylate, 98%
| 115314-14-2 |
|
2,5-Diaminobenzenesulfonic Acid, Tech. 90%
| 88-45-9 |
|
Selenium atomic absorption standard solution, 1 mg/ml se in 10% hcl
| 7647-01-0 |
|
6-Quinolinecarboxylic Acid, 98% (Titr.)
| 10349-57-2 |
|
2,2-Diphenylpropionic Acid, 97%
| 5558-66-7 |
|
4-Aminoantipyrine
| 83-07-8 |
|
Methyl 3,5-Dimethoxybenzoate, 99%
| 2150-37-0 |
|
N,2,3-Trimethyl-2-Isopropylbutamide
| 51115-67-4 |
|
|